$113 Million is the total value of Essex Woodlands Management, Inc.'s 6 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BVS | BIOVENTUS | $42,970,369 | +14.2% | 13,021,324 | 0.0% | 37.88% | +33.0% | |
| TELA | TELA BIO, INC. | $32,885,672 | -21.0% | 4,110,709 | 0.0% | 28.99% | -8.0% | |
| EYPT | Sell | EYEPOINT PHARMACEUTICALS INC | $27,892,459 | -23.5% | 3,490,921 | -16.7% | 24.59% | -10.9% |
| RVNC | REVANCE THERAPEUTICS INC | $5,242,765 | -54.7% | 457,085 | 0.0% | 4.62% | -47.2% | |
| MNOV | MEDICINOVA INC | $2,311,417 | -9.1% | 1,105,941 | 0.0% | 2.04% | +5.9% | |
| VERO | Buy | VENUS CONCEPT, INC. | $2,134,822 | -6.7% | 1,089,195 | +0.0% | 1.88% | +8.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.